Market Research Logo

Sangamo Therapeutics Inc (SGMO) - Financial and Strategic SWOT Analysis Review

Sangamo Therapeutics Inc (SGMO) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Sangamo Therapeutics Inc (Sangamo), formerly Sangamo BioSciences Inc, is a clinical stage biotechnology company that focuses on the research, development and commercialization of engineered DNA-binding proteins (ZFPs) for gene regulation, cell therapy and therapeutic genome editing. Its product candidates targets the treatment of HIV/AIDS, hemophilia A and B, hurler syndrome (MPS I), fabry disease, Huntington's disease and many others. Its ZFPs based products are used in various applications such as human therapeutics, research reagents, pharmaceutical protein production, plant agriculture, cell-line engineering and production of transgenic animals. The company has presence in the UK and the US. Sangamo is headquartered in Richmond, California, the US.

Sangamo Therapeutics Inc Key Recent Developments

Feb 21,2018: Sangamo Therapeutics Reports Fourth Quarter And Full Year 2017 Financial Results
Feb 13,2018: Sangamo Presents Oncology Genome Editing Capabilities at Keystone Symposium on Emerging Cellular Therapies
Feb 12,2018: Sangamo Therapeutics Appoints Heather D. Turner As Senior Vice President And General Counsel
Feb 07,2018: Case Western Reserve and Sangamo Therapeutics Announce $11 Million NIH Grant for Study of Gene-Edited T Cells for Viral Eradication of HIV
Jan 08,2018: Sangamo Therapeutics Outlines 2018 Key Priorities And Catalysts At J.P. Morgan Healthcare Conference

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Sangamo Therapeutics Inc - Key Facts
Sangamo Therapeutics Inc - Key Employees
Sangamo Therapeutics Inc - Key Employee Biographies
Sangamo Therapeutics Inc - Major Products and Services
Sangamo Therapeutics Inc - History
Sangamo Therapeutics Inc - Company Statement
Sangamo Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Sangamo Therapeutics Inc - Business Description
Sangamo Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Sangamo Therapeutics Inc - Strengths
Sangamo Therapeutics Inc - Weaknesses
Sangamo Therapeutics Inc - Opportunities
Sangamo Therapeutics Inc - Threats
Sangamo Therapeutics Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Sangamo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Sangamo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Sangamo Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 13, 2018: Sangamo Presents Oncology Genome Editing Capabilities at Keystone Symposium on Emerging Cellular Therapies
Feb 07, 2018: Case Western Reserve and Sangamo Therapeutics Announce $11 Million NIH Grant for Study of Gene-Edited T Cells for Viral Eradication of HIV
Jan 08, 2018: Sangamo Therapeutics Outlines 2018 Key Priorities And Catalysts At J.P. Morgan Healthcare Conference
Nov 09, 2017: Sangamo Therapeutics Reports Third Quarter 2017 Financial Results
Nov 09, 2017: Sangamo Announces Strategic Investment In Manufacturing And Appointment Of Andy Ramelmeier As Head Of Technical Operations
Nov 09, 2017: Sangamo Announces Plans For New Headquarters In Brisbane, California
Aug 31, 2017: Sangamo Presents T Cell Engineering Capabilities at Immuno-Oncology Summit
Aug 09, 2017: Sangamo Therapeutics Reports Second Quarter 2017 Financial Results
Jun 29, 2017: Sangamo Therapeutics Appoints Roger Jeffs, Ph.D. and Joseph S. Zakrzewski to its Board of Directors
May 15, 2017: Sangamo Therapeutics Presents Recent Developments from Research and Clinical Programs at Annual Meeting of the American Society of Gene & Cell Therapy
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Sangamo Therapeutics Inc, Key Facts
Sangamo Therapeutics Inc, Key Employees
Sangamo Therapeutics Inc, Key Employee Biographies
Sangamo Therapeutics Inc, Major Products and Services
Sangamo Therapeutics Inc, History
Sangamo Therapeutics Inc, Subsidiaries
Sangamo Therapeutics Inc, Key Competitors
Sangamo Therapeutics Inc, Ratios based on current share price
Sangamo Therapeutics Inc, Annual Ratios
Sangamo Therapeutics Inc, Annual Ratios (Cont...1)
Sangamo Therapeutics Inc, Interim Ratios
Sangamo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Sangamo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Sangamo Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Sangamo Therapeutics Inc, Performance Chart (2013 - 2017)
Sangamo Therapeutics Inc, Ratio Charts
Sangamo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Sangamo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report